Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated Pneumonia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Stroke-associated pneumonia (SAP) is the major complication of acute intracerebral
haemorrhage (AICH), leads to poor clinical outcomes and increases the financial burden on the
medical system. Prophylactic antibiotics do not reduce the mortality rate of SAP. The
Tong-Fu-Xing-Shen herbal formula (TFXS) was shown to be effective for the prevention and
treatment SAP in a previous clinical trial. To clarify whether TFXS is effective and safe for
the treatment of SAP and affects the immunological mechanism of the "brain-gut-lung" pathway
of SAP, the investigators designed this study.
Phase:
Phase 4
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Collaborators:
Ganzhou People's Hospital Affiliated to Nanchang University Guangdong Provincial Hospital of Traditional Chinese Medicine Lianjiang Hospital of Traditional Chinese Medicine Liaoning Tumor Hospital & Institute People's Hospital of Ganzhou City People's Hospital of Lianjiang City Shenyang No. 2 Hospital of Traditional Chinese Medicine Yangjiang Hospital of Traditional Chinese Medicine